Emerging Pathogens Institute

Last updated
Emerging Pathogens Institute
Emerging Pathogens Institute.jpg
The Emerging Pathogen Research Facility
Established2007
Director J. Glenn Morris
Location,
USA
Website Official website

The Emerging Pathogens Institute (EPI) is an interdisciplinary research institution associated with the University of Florida. The institute focuses on fusing key disciplines to develop outreach, education, and research capabilities designed to preserve the region's health and economy, as well as to prevent or contain new and re-emerging diseases. [1] Researchers within the institute work in more than 30 different countries around the world, with over 250 affiliated faculty members stemming from 11 University of Florida colleges, centers, and institutes. The 90,000-square-foot building includes laboratories and collaborative space for bioinformatics and mathematical modeling.Ebrahim Ahmadpour

Contents

History

The idea of this institute was first created by the University of Florida faculty and researchers, prompted by the recognition of a need for a facility that could drive pathogen-related research in FlorUida. Funding for the EPI was provided by the Florida State Legislature in 2006. In 2007, Dr. J. Glenn Morris was recruited from the University of Maryland, Baltimore to serve as the founding director of the EPI. Construction on a new, dedicated 90,000-square-foot research facility was completed in 2009. The structure houses the institute and numerous top researchers, as well as the Southeastern National Tuberculosis Center (SNTC), the Southern HIV and Alcohol Research Consortium (SHARC) and one of the CDC Centers of Excellence in Vector-borne Diseases. [2]

In March 2009, the institute received a substantial grant from the Bill and Melinda Gates Foundation. This was the first time that the University of Florida has ever received direct funding from this foundation, and the grant was provided to help researchers develop tools to fight malaria. [3]

Major areas of research

Global research

The Emerging Pathogens Institute channels multidisciplinary programs focused on plant, human and animal pathogens, including viral discovery, vector-borne pathogens and, most recently, coronaviruses and pandemic preparedness. Publications include papers in top scientific journals, including Science, Nature and Proceedings of the National Academy of Sciences. Given the speed with which pathogens can move globally, work in the EPI has had a strong international focus, with collaborations in place with investigators in over 50 countries.

EPI investigators have been involved in research on various coronavirus species for a number of years. With the onset of the pandemic, the EPI has played a role in population-based studies of COVID-19, including studies of transmission within schools. [4] Other areas of research have included development of mathematical models predicting spread of the virus in Florida in successive pandemic waves, [5] the critical role of aerosols in transmission of the virus [6] [7] [8] and the transmission of coronaviruses of animal origin into humans. [9] [10]

Directors

2007Present J. Glenn Morris

See also

Related Research Articles

<span class="mw-page-title-main">Zoonosis</span> Disease that can be transmitted from other species to humans

A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human to a human and vice versa.

<span class="mw-page-title-main">Infection</span> Invasion of an organisms body by pathogenic agents

An infection is the invasion of tissues by pathogens, their multiplication, and the reaction of host tissues to the infectious agent and the toxins they produce. An infectious disease, also known as a transmissible disease or communicable disease, is an illness resulting from an infection.

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

EcoHealth Alliance is a US-based non-governmental organization with a stated mission of protecting people, animals, and the environment from emerging infectious diseases. The nonprofit is focused on research that aims to prevent pandemics and promote conservation in hotspot regions worldwide.

<span class="mw-page-title-main">Emerging infectious disease</span> Infectious disease of emerging pathogen, often novel in its outbreak range or transmission mode

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently, and could increase in the near future. The minority that are capable of developing efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical. EIDs have been increasing steadily since at least 1940.

An emergent virus is a virus that is either newly appeared, notably increasing in incidence/geographic range or has the potential to increase in the near future. Emergent viruses are a leading cause of emerging infectious diseases and raise public health challenges globally, given their potential to cause outbreaks of disease which can lead to epidemics and pandemics. As well as causing disease, emergent viruses can also have severe economic implications. Recent examples include the SARS-related coronaviruses, which have caused the 2002-2004 outbreak of SARS (SARS-CoV-1) and the 2019–21 pandemic of COVID-19 (SARS-CoV-2). Other examples include the human immunodeficiency virus which causes HIV/AIDS; the viruses responsible for Ebola; the H5N1 influenza virus responsible for avian flu; and H1N1/09, which caused the 2009 swine flu pandemic. Viral emergence in humans is often a consequence of zoonosis, which involves a cross-species jump of a viral disease into humans from other animals. As zoonotic viruses exist in animal reservoirs, they are much more difficult to eradicate and can therefore establish persistent infections in human populations.

<span class="mw-page-title-main">W. Ian Lipkin</span> Professor, microbiologist, epidemiologist

Walter Ian Lipkin is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University and a professor of Neurology and Pathology at the College of Physicians and Surgeons at Columbia University. He is also director of the Center for Infection and Immunity, an academic laboratory for microbe hunting in acute and chronic diseases. Lipkin is internationally recognized for his work with West Nile virus, SARS and COVID-19.

<span class="mw-page-title-main">Airborne transmission</span> Disease transmission by airborne particles

Airborne transmission or aerosol transmission is transmission of an infectious disease through small particles suspended in the air. Infectious diseases capable of airborne transmission include many of considerable importance both in human and veterinary medicine. The relevant infectious agent may be viruses, bacteria, or fungi, and they may be spread through breathing, talking, coughing, sneezing, raising of dust, spraying of liquids, flushing toilets, or any activities which generate aerosol particles or droplets. This is the transmission of diseases via transmission of an infectious agent, and does not include diseases caused by air pollution.

Novel coronavirus (nCoV) is a provisional name given to coronaviruses of medical significance before a permanent name is decided upon. Although coronaviruses are endemic in humans and infections normally mild, such as the common cold, cross-species transmission has produced some unusually virulent strains which can cause viral pneumonia and in serious cases even acute respiratory distress syndrome and death.

<span class="mw-page-title-main">Human coronavirus OC43</span> Species of virus

Human coronavirus OC43 (HCoV-OC43) is a member of the species Betacoronavirus 1, which infects humans and cattle. The infecting coronavirus is an enveloped, positive-sense, single-stranded RNA virus that enters its host cell by binding to the N-acetyl-9-O-acetylneuraminic acid receptor. OC43 is one of seven coronaviruses known to infect humans. It is one of the viruses responsible for the common cold and may have been responsible for the 1889–1890 pandemic. It has, like other coronaviruses from genus Betacoronavirus, subgenus Embecovirus, an additional shorter spike protein called hemagglutinin-esterase (HE).

Spillover infection, also known as pathogen spillover and spillover event, occurs when a reservoir population with a high pathogen prevalence comes into contact with a novel host population. The pathogen is transmitted from the reservoir population and may or may not be transmitted within the host population. Due to climate change and land use expansion, the risk of viral spillover is predicted to significantly increase.

John Glenn Morris, Jr. is an American physician and epidemiologist. He is the founding and current director of the Emerging Pathogens Institute, an interdisciplinary research facility located within the University of Florida, having served since 2007.

<span class="mw-page-title-main">SARS-CoV-2</span> Virus that causes COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.

Pandemic prevention is the organization and management of preventive measures against pandemics. Those include measures to reduce causes of new infectious diseases and measures to prevent outbreaks and epidemics from becoming pandemics.

<span class="mw-page-title-main">Peter Daszak</span> British zoologist

Peter Daszak is a British zoologist, consultant and public expert on disease ecology, in particular on zoonosis. He is the president of EcoHealth Alliance, a nonprofit non-governmental organization that supports various programs on global health and pandemic prevention. He is also a member of the Center for Infection and Immunity at the Columbia University Mailman School of Public Health. He lives in Suffern, New York.

<span class="mw-page-title-main">Müge Çevik</span> Physician, infectious disease researcher and science communicator

Müge Çevik is a physician who is an infectious diseases researcher and science communicator at the University of St Andrews. Her research considers HIV, viral hepatitis, emerging infections and tropical infections in developing countries. During the COVID-19 pandemic, Çevik was an advisor to the Chief Medical Officer of Scotland and the World Health Organization, and is a member of New and Emerging Respiratory Virus Threats Advisory Group - an expert committee of the UK Department of Health advising Scientific Advisory Group for Emergencies.

<span class="mw-page-title-main">Source control (respiratory disease)</span> Strategy for reducing disease transmission

Source control is a strategy for reducing disease transmission by blocking respiratory secretions produced through speaking, coughing, sneezing or singing. Surgical masks are commonly used for this purpose, with cloth face masks recommended for use by the public only in epidemic situations when there are shortages of surgical masks. In addition, respiratory etiquette such as covering the mouth and nose with a tissue when coughing can be considered source control. In diseases transmitted by droplets or aerosols, understanding air flow, particle and aerosol transport may lead to rational infrastructural source control measures that minimize exposure of susceptible persons.

<span class="mw-page-title-main">Transmission of COVID-19</span> Mechanisms that spread coronavirus disease 2019

The transmission of COVID-19 is the passing of coronavirus disease 2019 from person to person. COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.

<span class="mw-page-title-main">David Hayman (disease ecologist)</span> New Zealand epizootic epidemiologist

David Hayman is a New Zealand-based epizootic epidemiologist and disease ecologist whose general multi-disciplinary work focuses on the maintenance of infectious diseases within their hosts and the process of emergence and transmission to humans specifically related to bats. He has gathered data on the relationship between ecological degradation due to anthropogenic actions, and increased pathogen emergence in humans and animals. During COVID-19 he was involved as an expert in several international collaborations, some convened by the World Health Organization, and was a regular commentator in the New Zealand media about the country's response to the pandemic. He has had lead roles in research organisations at Massey University and Te Pūnaha Matatini and was the recipient of the 2017 Rutherford Discovery Fellowship Award. Since 2014 Hayman has been a professor at Massey University.

<span class="mw-page-title-main">Endemic COVID-19</span> Theoretical future stage of COVID-19

COVID-19 is predicted to become an endemic disease by many experts. The observed behavior of SARS-CoV-2, the virus that causes COVID-19, suggests it is unlikely it will die out, and the lack of a COVID-19 vaccine that provides long-lasting immunity against infection means it cannot immediately be eradicated; thus, a future transition to an endemic phase appears probable. In an endemic phase, people would continue to become infected and ill, but in relatively stable numbers. Such a transition may take years or decades. Precisely what would constitute an endemic phase is contested.

References

  1. "Emerging Pathogens Institute - University of Florida". epi.ufl.edu.
  2. "Florida breaks ground for pathogen research lab - DVM Newsmagazine | HighBeam Research". October 22, 2012. Archived from the original on 2012-10-22.
  3. Crabbe N. "Gates Foundation gives grant to UF". Gainesville Sun.
  4. Nelson EJ, McKune SL, Ryan KA, Shapiro J, Mott-Young AH, Myers PD, Morris JG (March 2022). "Antigen vs RT-PCR Tests for Screening Quarantined Students in Florida During the COVID-19 Pandemic SARS-CoV-2 Delta Variant Surge". JAMA Pediatrics. 176 (5): 525–526. doi:10.1001/jamapediatrics.2022.0080. PMC   8902689 . PMID   35254393.
  5. Hladish TJ, Pillai AN, Longini IM (January 2022). "Updated projections for COVID-19 omicron wave in Florida". medRxiv   10.1101/2022.01.06.22268849 .
  6. Lednicky JA, Shankar SN, Elbadry MA, Gibson JC, Alam MM, Stephenson CJ, et al. (June 2020). "Collection of SARS-CoV-2 Virus from the Air of a Clinic Within a University Student Health Care Center and Analyses of the Viral Genomic Sequence". Aerosol and Air Quality Research. 20 (6): 1167–1171. doi:10.4209/aaqr.2020.05.0202. PMC   7792982 . PMID   33424954.
  7. Lednicky JA, Lauzard M, Fan ZH, Jutla A, Tilly TB, Gangwar M, et al. (November 2020). "Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients". International Journal of Infectious Diseases. 100: 476–482. doi:10.1016/j.ijid.2020.09.025. PMC   7493737 . PMID   32949774.
  8. Lednicky JA, Lauzardo M, Alam MM, Elbadry MA, Stephenson CJ, Gibson JC, Morris JG (July 2021). "Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness". International Journal of Infectious Diseases. 108: 212–216. doi:10.1016/j.ijid.2021.04.063. PMC   8064821 . PMID   33901650.
  9. Lednicky JA, Tagliamonte MS, White SK, Elbadry MA, Alam MM, Stephenson CJ, et al. (December 2021). "Independent infections of porcine deltacoronavirus among Haitian children". Nature. 600 (7887): 133–137. Bibcode:2021Natur.600..133L. doi:10.1038/s41586-021-04111-z. PMC   8636265 . PMID   34789872.
  10. Lednicky JA, Tagliamonte MS, White SK, Blohm GM, Alam MM, Iovine NM, et al. (October 2021). "Isolation of a Novel Recombinant Canine Coronavirus from a Visitor to Haiti: Further Evidence of Transmission of Coronaviruses of Zoonotic Origin to Humans". Clinical Infectious Diseases. 75 (1): e1184–e1187. doi:10.1093/cid/ciab924. PMC   9402678 . PMID   34718467.

29°38′14″N82°21′07″W / 29.637187°N 82.352038°W / 29.637187; -82.352038